Myriad Genetics, Inc. (LON: 0K3W)
London
· Delayed Price · Currency is GBP · Price in USD
12.65
0.00 (0.00%)
Jan 22, 2025, 3:30 PM BST
Myriad Genetics Revenue
Myriad Genetics had revenue of $213.30M USD in the quarter ending September 30, 2024, with 11.15% growth. This brings the company's revenue in the last twelve months to $823.60M, up 12.15% year-over-year. In the year 2023, Myriad Genetics had annual revenue of $753.20M with 11.03% growth.
Revenue (ttm)
$823.60M
Revenue Growth
+12.15%
P/S Ratio
n/a
Revenue / Employee
$305.04K
Employees
2,700
Market Cap
907.69M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 753.20M | 74.80M | 11.03% |
Dec 31, 2022 | 678.40M | -12.20M | -1.77% |
Dec 31, 2021 | 690.60M | 133.60M | 23.99% |
Dec 31, 2020 | 557.00M | -81.60M | -12.78% |
Jun 30, 2020 | 638.60M | -212.50M | -24.97% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Myriad Genetics News
- 6 days ago - Myriad Genetics: Navigating Through A Setback - Seeking Alpha
- 7 days ago - Myriad Genetics Inc (MYGN) Announces Preliminary 2024 Financial Results and 2025 Guidance - GuruFocus
- 8 days ago - Myriad Genetics expects Q4 revenues to be between $209M and $211M - Seeking Alpha
- 8 days ago - Diligent Announces Market Insights Reporting Powered by S&P Global Market Intelligence, Giving Directors and Executives Unrivaled Financial and Risk Insights - Business Wire
- 13 days ago - Myriad Genetics Inc (MYGN) Partners with Hannah Storm to Promote Breast Cancer Risk Awareness - GuruFocus
- 13 days ago - Myriad Genetics Partners with Hannah Storm to Promote Breast Cancer Risk Awareness - GuruFocus
- 13 days ago - Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History - GlobeNewsWire
- 14 days ago - UPDATE – Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire